临床表现 临床表现
Jackson C Thompson1, Jessie Fanglu Fu1,2, Michelle E Farrell3
1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
像DCTclock这样的数字认知评估显示出早期阿尔茨海默病 (AD) 变化检测的希望. 纵向研究显示,DCTclock捕获了关于粉样蛋白传播的独特信息,而PACC在晚期认知衰退方面仍然优越.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 生物医学工程 生物医学工程
背景情况:
- 数字认知评估为早期发现阿尔茨海默病 (AD) 病理学提供了潜力.
- 粉样β (Ab) 传播的空间范围 (EXT) 可能对早期的Ab负担比传统措施更敏感.
- 以前的横截面数据将恶化的数字时钟绘图测试 (DCTclock) 性能与认知正常 (CN) 个体中的粉样蛋白和蛋白联系在一起.
研究的目的:
- 纵向评估粉样蛋白扩散 (EXT) 和脑内与认知衰退在认知正常的老年人之间的关系.
- 评估数字时钟绘图测试 (DCTclock) 在捕捉与临床前阿尔茨海默病相关的早期认知变化的实用性.
主要方法:
- 195名认知正常的老年人每年接受DCT时钟和PACC5评估,长达6年.
- 在基线测量时测量了粉样蛋白PET ([11C]匹兹堡化合物B) 和内分泌PET (Flortaucipir SUVR).
- 用空间范围 (EXT) 来量化 Amyloid 的分布,将参与者分为 EXT,EXT+ 和 EXT++ 组.
主要成果:
- 与EXT-组相比,EXT+和EXT++组的个体在PACC5和DCT时钟信息处理子评分 (DCT-IP) 上表现出明显更快的认知衰退.
- 升高的内分泌和粉样蛋白扩散 (EXT+/EXT++) 独立地预测了更快的PACC5衰退.
- 在EXT+组中,DCT-IP下降速度更快是显著的,这表明对早期粉样蛋白传播的敏感性.
结论:
- 纵向DCT时钟评估为在粉样蛋白传播的早期阶段对认知衰退提供了独特的见解.
- 在较晚的临床前AD阶段,PACC仍然是评估与粉样蛋白和蛋白病理相关的严重认知衰退的更强有力的措施.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


